← FDA Drug Approvals (Drugs@FDA)

KHAPZORY

NDA · New Drug Application · Sponsor: ACROTECH BIOPHARMA · Approved 2018-10-19

Drug application

FDA Application #

NDA211226

Application type

New Drug Application

Brand name

KHAPZORY

Generic name

LEVOLEUCOVORIN

Active ingredients

LEVOLEUCOVORIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ACROTECH BIOPHARMA

Manufacturer

Acrotech Biopharma Inc

First approval

2018-10-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown